The debate over banning or legalizing pot has been going on for regarding green century now, but it continues to be a fresh issue on the table. There are people who strongly support its legalization, while there are many who vehemently oppose it. However, during the last decade, the debate has been tilted in favor of cannabis as the term “medical marijuana” has gained momentum with the help of legalization campaigns. Still, there are others who are preventing it from going it all legal.
The findings of a recent study also go in favor of optimum medical use of pot. It says that a certain chemical found in pot can actually assist in treating patients with drug-resistant forms of epilepsy. This new study has provided evidence that pot can be effective in treatment for one-third of epilepsy patients who have a treatment-resistant form of the illness.
The study called “Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial” — published in the Lancet Neurology — says that almost one-third of epilepsy patients are treatment-resistant and are associated with severe morbidity and increased mortality. CBD roller Though marijuana-based treatments for epilepsy have spiked the interest of the people, scientific data on the subject is very limited, feel the authors.
“We aimed to determine whether addition of cannabidiol to existing anti-epileptic routines would be safe, tolerated, and effective in children and adults with treatment-resistant epilepsy, inch the researchers said.
The researchers, led by Orrin Devinsky, a neurologist at New york University Langone Hospital, administered an remove of 99 percent cannabidiol (CBD) — a non-psychoactive chemical in pot — to 162 patients and administered them approximately 12 weeks. The chemical was handed as a supplement or add-on along with other preexisting medicines of the patients and was conducted on an open level, which means everybody was aware of what these were given. The researchers observed that this involvement were able to reduce to motor seizures at a similar rate by the existing drugs, but 2 percent of patients became completely seizure free.
Despite some good success being shown by this method, the researchers feel that there is need for further extensive studies on the subject. “Our findings claim that cannabidiol might reduce seizure frequency and might have an adequate safety profile in children and adults with highly treatment-resistant epilepsy. Randomized controlled studies are warranted to characterize the safety profile and true efficacy of this compound, inch the study said.
This is not the first time when this remark has been made. Some previous studies had also drawn similar a conclusion. A 2007 study, called “Marijuana: An effective Antiepileptic Treatment in Part Epilepsy? A case Report and Review of the Literature, inch published in the Reviews in Neurological Diseases had also said that “marijuana or its active constituents may have a place in treating part epilepsy. inch
Katherine Mortati, Michael. D., a neurologist at the Comprehensive Epilepsy Center at SUNY Downstate Hospital, who had conducted the study, said “In the study we present the case of a 45-year-old man with cerebral palsy and epilepsy who showed marked improvement with the use of pot. This case supports other anecdotal data suggesting that pot use may be a beneficial adjunctive treatment in some patients with epilepsy. inch